Activ-6

ACTIV-6 And TOGETHER Bear Strangely Similar Design Fingerprints

A while ago, I wrote an article enumerating ten questionable features of the TOGETHER trial on ivermectin, conducted in Brazil.

Nov 15, 2022 •

Alexandros Marinos

ACTIV-6 Dosing & Timing: A Fox In The Henhouse

Trying to understand what I learned in my conversation with the ACTIV-6 patient, I looked at who is actually responsible for the ACTIV trials.

Nov 2, 2022 •

Alexandros Marinos

The Story Of A Real ACTIV-6 Patient

This could only have happened in the era of Twitter: when I posted my previous article on the ACTIV-6 trial on ivermectin, I came in contact with a…

Oct 31, 2022 •

Alexandros Marinos

ACTIV-6 Trial on Ivermectin: NIH Scientists Behaving Badly

You may have heard that a new NIH-funded Randomized Controlled Trial was published recently. This one most definitely proves ivermectin doesn’t work for…

Oct 28, 2022 •

Alexandros Marinos

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts